DE3379964D1 - Method for removing impurities from leukocyte interferon preparations, and purified leukocyte iterferon produced thereby - Google Patents

Method for removing impurities from leukocyte interferon preparations, and purified leukocyte iterferon produced thereby

Info

Publication number
DE3379964D1
DE3379964D1 DE8383306614T DE3379964T DE3379964D1 DE 3379964 D1 DE3379964 D1 DE 3379964D1 DE 8383306614 T DE8383306614 T DE 8383306614T DE 3379964 T DE3379964 T DE 3379964T DE 3379964 D1 DE3379964 D1 DE 3379964D1
Authority
DE
Germany
Prior art keywords
leukocyte
iterferon
produced
removing impurities
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383306614T
Other languages
English (en)
Inventor
Paul D Johnston
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of DE3379964D1 publication Critical patent/DE3379964D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Peptides Or Proteins (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8383306614T 1982-11-01 1983-10-31 Method for removing impurities from leukocyte interferon preparations, and purified leukocyte iterferon produced thereby Expired DE3379964D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/438,129 US4534906A (en) 1982-11-01 1982-11-01 Removal of impurities from human leukocyte interferon preparations

Publications (1)

Publication Number Publication Date
DE3379964D1 true DE3379964D1 (en) 1989-07-06

Family

ID=23739353

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383306614T Expired DE3379964D1 (en) 1982-11-01 1983-10-31 Method for removing impurities from leukocyte interferon preparations, and purified leukocyte iterferon produced thereby

Country Status (10)

Country Link
US (1) US4534906A (de)
EP (1) EP0108585B1 (de)
JP (1) JPS5998096A (de)
AT (1) ATE43639T1 (de)
AU (1) AU575304B2 (de)
CA (1) CA1211711A (de)
DE (1) DE3379964D1 (de)
DK (1) DK160617C (de)
IE (1) IE56181B1 (de)
ZA (1) ZA838109B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8401911A (nl) * 1984-06-15 1986-01-02 Stichting Rega V Z W Antiviraal proteine, werkwijze voor het produceren daarvan, en farmaceutische preparaten die dit proteine bevatten.
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
US5196323A (en) * 1985-04-27 1993-03-23 Boehringer Ingelheim International Gmbh Process for preparing and purifying alpha-interferon
US4961969A (en) * 1987-05-11 1990-10-09 Cetus Corporation Process for recovering microbially produced interferon-β
ATE78698T1 (de) * 1987-10-06 1992-08-15 Interferon Sciences Inc Reinigung von monomerem interferon.
US4765903A (en) * 1987-10-06 1988-08-23 Interferon Sciences, Inc. Purification of monomeric interferon
US5182369A (en) * 1990-02-28 1993-01-26 Monsanto Company Method for purifying somatotropin monomers
AU2592395A (en) * 1994-05-19 1995-12-18 Monsanto Company Method for purifying somatotropin monomers
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
EP2236156A3 (de) * 2001-01-09 2011-01-05 Baylor Research Institute Verfahren zur Behandlung und Diagnose von Psoriasis
ITBO20010426A1 (it) * 2001-07-06 2003-01-06 Alfa Wassermann Spa Processo per la purificazione di proteine farmacologicamente attive mediante cromatografia in scambio cationico
KR100531670B1 (ko) * 2003-12-03 2005-11-28 씨제이 주식회사 인체 인터페론 알파의 제조방법
EP2195338B1 (de) 2007-10-01 2013-12-25 Pharmaessentia Corp. N-terminal modifiziertes interferon-alpha
CA2746502A1 (en) 2008-12-23 2010-07-01 Xiaoyu Yang Purification of recombinantly produced interferon
JP6431851B2 (ja) * 2013-12-25 2018-11-28 株式会社海月研究所 水不溶性高分子化合物の分解物の連続的製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN150740B (de) * 1978-11-24 1982-12-04 Hoffmann La Roche
ZA796175B (en) * 1978-11-24 1980-11-26 Hoffmann La Roche Purified proteins and process therefor
FI77877C (fi) * 1979-04-20 1989-05-10 Technobiotic Ltd Foerfarande foer framstaellning och rening av human le-formig interferonprotein.
AU8736282A (en) * 1981-08-13 1983-02-22 American National Red Cross, The Filtration method for cell produced antiviral substances

Also Published As

Publication number Publication date
DK160617B (da) 1991-04-02
JPH0434560B2 (de) 1992-06-08
IE832542L (en) 1984-05-01
DK498183A (da) 1984-05-02
AU575304B2 (en) 1988-07-28
EP0108585B1 (de) 1989-05-31
EP0108585A3 (en) 1985-07-31
JPS5998096A (ja) 1984-06-06
AU2085583A (en) 1984-05-10
ATE43639T1 (de) 1989-06-15
US4534906A (en) 1985-08-13
IE56181B1 (en) 1991-05-08
DK498183D0 (da) 1983-10-31
CA1211711A (en) 1986-09-23
DK160617C (da) 1991-09-16
ZA838109B (en) 1984-09-26
EP0108585A2 (de) 1984-05-16

Similar Documents

Publication Publication Date Title
DE3379964D1 (en) Method for removing impurities from leukocyte interferon preparations, and purified leukocyte iterferon produced thereby
IE902095L (en) Process for preparing ascorbic acid
CA1267497C (en) PROTEIN RECOVERY
ES8504255A1 (es) Procedimiento para la produccion de una hormona de crecimiento de porcino.
AU589569B2 (en) Method for recovering purified growth hormones from genetically engineered microorganisms
ES8700272A1 (es) Procedimiento para la preparacion y purificacion de peptidos
GB1375811A (de)
EP0270516A3 (en) Process for the preparation of a fraction containing factor viii (ahf)
CA1273592C (en) ISOLATION OF A BIOACTIVE MONOMER GROWTH HORMONE
EP0242799A3 (en) Cystein-enriched unities of gamma-glutamic acid and beta-alanine, process for their preparation and their use
HU904388D0 (en) Method for recovering recombinant proteins
EP0085220A3 (de) Verfahren zur Reinigung des Hormons der vorderen Hypophyse
JPS57179123A (en) Purification of number viii factor-containing aqueous solution
AU590791B2 (en) Treatment of rare earth ores
GB1440842A (en) Immunological adjuvants and process for their preparation
RO103684A2 (en) PRODUCTION METHOD OF IMMUNO-GLOBULIN A1(IgA1)